Robust Generation of Quiescent Porcine Valvular Interstitial Cell Cultures

Background Valvular interstitial cells (VICs) in the healthy aortic valve leaflet exhibit a quiescent phenotype, with <5% of VICs exhibiting an activated phenotype. Yet, in vitro culture of VICs on tissue culture polystyrene surfaces in standard growth medium results in rapid transformation to an activated phenotype in >90% of cells. The inability to preserve a healthy VIC phenotype during in vitro studies has hampered the elucidation of mechanisms involved in calcific aortic valve disease. This study describes the generation of quiescent populations of porcine VICs in 2‐dimensional in vitro culture and their utility in studying valve pathobiology. Methods and Results Within 4 days of isolation from fresh porcine hearts, VICs cultured in standard growth conditions were predominantly myofibroblastic (activated VICs). This myofibroblastic phenotype was partially reversed within 4 days, and fully reversed within 9 days, following application of a combination of a fibroblast media formulation with culture on collagen coatings. Specifically, culture in this combination significantly reduced several markers of VIC activation, including proliferation, apoptosis, α‐smooth muscle actin expression, and matrix production, relative to standard growth conditions. Moreover, VICs raised in a fibroblast media formulation with culture on collagen coatings exhibited dramatically increased sensitivity to treatment with transforming growth factor β1, a known pathological stimulus, compared with VICs raised in either standard culture or medium with a fibroblast media formulation. Conclusions The approach using a fibroblast media formulation with culture on collagen coatings generates quiescent VICs that more accurately mimic a healthy VIC population and thus has the potential to transform the study of the mechanisms of VIC activation and dysfunction involved in the early stages of calcific aortic valve disease.

[1]  K. Anseth,et al.  Role of cell–matrix interactions on VIC phenotype and tissue deposition in 3D PEG hydrogels , 2016, Journal of tissue engineering and regenerative medicine.

[2]  K. Eliceiri,et al.  Calcific Aortic Valve Disease Is Associated with Layer-Specific Alterations in Collagen Architecture , 2016, PloS one.

[3]  R. Magin,et al.  Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture. , 2016, Acta biomaterialia.

[4]  Marcella Trombetta,et al.  Cells and extracellular matrix interplay in cardiac valve disease: because age matters , 2016, Basic Research in Cardiology.

[5]  L. Wilkins Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology , 2016, Journal of the American Heart Association.

[6]  Kristi S Anseth,et al.  Microarray analyses to quantify advantages of 2D and 3D hydrogel culture systems in maintaining the native valvular interstitial cell phenotype. , 2016, Biomaterials.

[7]  M. Yacoub,et al.  Modulation of Human Valve Interstitial Cell Phenotype and Function Using a Fibroblast Growth Factor 2 Formulation , 2015, PloS one.

[8]  Magdi H Yacoub,et al.  Expression of smooth muscle cell markers and co-activators in calcified aortic valves. , 2015, European heart journal.

[9]  Meghan A Bowler,et al.  In vitro models of aortic valve calcification: solidifying a system. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[10]  Joshua D. Hutcheson,et al.  Directing Valvular Interstitial Cell Myofibroblast‐Like Differentiation in a Hybrid Hydrogel Platform , 2015, Advanced healthcare materials.

[11]  L. Leinwand,et al.  Cardiac valve cells and their microenvironment—insights from in vitro studies , 2014, Nature Reviews Cardiology.

[12]  Guang Yao Modelling mammalian cellular quiescence , 2014, Interface Focus.

[13]  K. Masters,et al.  Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification , 2014, BMC Cardiovascular Disorders.

[14]  Mark W. Tibbitt,et al.  Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway , 2013, Proceedings of the National Academy of Sciences.

[15]  Tom H. Cheung,et al.  Molecular regulation of stem cell quiescence , 2013, Nature Reviews Molecular Cell Biology.

[16]  A. Gotlieb,et al.  The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[17]  Joshua D. Hutcheson,et al.  5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation. , 2012, Journal of molecular and cellular cardiology.

[18]  K. Masters,et al.  A time course investigation of the statin paradox among valvular interstitial cell phenotypes. , 2012, American journal of physiology. Heart and circulatory physiology.

[19]  K. Billiar,et al.  Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation. , 2012, Journal of biomedical materials research. Part A.

[20]  A. Teleman,et al.  Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP. , 2012, Developmental biology.

[21]  April M. Kloxin,et al.  Redirecting Valvular Myofibroblasts into Dormant Fibroblasts through Light-mediated Reduction in Substrate Modulus , 2012, PloS one.

[22]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[23]  K. Masters,et al.  Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. , 2011, The Journal of heart valve disease.

[24]  Craig A Simmons,et al.  Cell–Matrix Interactions in the Pathobiology of Calcific Aortic Valve Disease: Critical Roles for Matricellular, Matricrine, and Matrix Mechanics Cues , 2011, Circulation research.

[25]  Craig A Simmons,et al.  The aortic valve microenvironment and its role in calcific aortic valve disease. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[26]  Kristyn S Masters,et al.  Regulation of valvular interstitial cell calcification by adhesive peptide sequences. , 2010, Journal of biomedical materials research. Part A.

[27]  B. Hinz,et al.  The myofibroblast: paradigm for a mechanically active cell. , 2010, Journal of biomechanics.

[28]  Kristi S Anseth,et al.  Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. , 2009, Biomaterials.

[29]  Kristyn S Masters,et al.  Regulation of valvular interstitial cell calcification by components of the extracellular matrix. , 2009, Journal of biomedical materials research. Part A.

[30]  Craig A Simmons,et al.  Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Craig A Simmons,et al.  Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. , 2009, The American journal of pathology.

[32]  J. Cleveland,et al.  Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. , 2009, Journal of the American College of Cardiology.

[33]  Kristi S Anseth,et al.  Substrate properties influence calcification in valvular interstitial cell culture. , 2008, The Journal of heart valve disease.

[34]  A. Gotlieb,et al.  Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells. , 2008, The American journal of pathology.

[35]  K. Anseth,et al.  Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  V. Joag,et al.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. , 2007, The American journal of pathology.

[37]  H. Jakubowski,et al.  Letter by Undas and Jakubowski regarding article, "Relationship between homocysteine and mortality in chronic kidney disease". , 2006, Circulation.

[38]  M. Amrani,et al.  Role of Human Valve Interstitial Cells in Valve Calcification and Their Response to Atorvastatin , 2006, Circulation.

[39]  E. Mohler,et al.  Paradoxical Effects of Statins on Aortic Valve Myofibroblasts and Osteoblasts: Implications for End-Stage Valvular Heart Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[40]  L. Leinwand,et al.  Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease , 2004, Circulation research.

[41]  R. Levy,et al.  Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. , 2003, The Annals of thoracic surgery.

[42]  M. Yacoub,et al.  Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. , 2000, The Journal of heart valve disease.

[43]  C M Johnson,et al.  Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics. , 1987, Journal of molecular and cellular cardiology.